nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
A molecular roadmap for midostaurin in mastocytosis
|
Gotlib, Jason |
|
|
130 |
2 |
p. 98-100 |
artikel |
2 |
Association between diffuse myocardial fibrosis and diastolic dysfunction in sickle cell anemia
|
Niss, Omar |
|
|
130 |
2 |
p. 205-213 |
artikel |
3 |
Bruised platelet transfusions work
|
Kickler, Thomas S. |
|
|
130 |
2 |
p. 106-107 |
artikel |
4 |
Cannavò A, Valsecchi C, Garagiola I, et al. Nonneutralizing antibodies against factor VIII and risk of inhibitor development in severe hemophilia A. Blood. 2017;129(10):1245-1250.
|
|
|
|
130 |
2 |
p. 232 |
artikel |
5 |
CART attack
|
Pillai, Vinodh |
|
|
130 |
2 |
p. 229 |
artikel |
6 |
Checking up on checkpoint inhibitors
|
Little, Richard F. |
|
|
130 |
2 |
p. 107-108 |
artikel |
7 |
Circulating soluble P-selectin must dimerize to promote inflammation and coagulation in mice
|
Panicker, Sumith R. |
|
|
130 |
2 |
p. 181-191 |
artikel |
8 |
Diagnosing therapy-related acute myeloid leukemia with 8% blasts in bone marrow with concomitant plasma cell myeloma
|
Thakral, Beenu |
|
|
130 |
2 |
p. 231 |
artikel |
9 |
Editorial Board
|
|
|
|
130 |
2 |
p. i |
artikel |
10 |
Effect of a near-universal hospitalization-based prophylaxis regimen on annual number of venous thromboembolism events in the US
|
Heit, John A. |
|
|
130 |
2 |
p. 109-114 |
artikel |
11 |
Factor V marks platelet-primed megakaryocytes
|
Bertoni, Alessandra |
|
|
130 |
2 |
p. 102-103 |
artikel |
12 |
Fischer K, Al-Sawaf O, Fink A-M, et al. Venetoclax and obinutuzumab in chronic lymphocytic leukemia. Blood. 2017;129(19):2702-2705.
|
|
|
|
130 |
2 |
p. 232 |
artikel |
13 |
Functional evidence for derivation of systemic histiocytic neoplasms from hematopoietic stem/progenitor cells
|
Durham, Benjamin H. |
|
|
130 |
2 |
p. 176-180 |
artikel |
14 |
Hematopoietic origin of Langerhans cell histiocytosis and Erdheim-Chester disease in adults
|
Milne, Paul |
|
|
130 |
2 |
p. 167-175 |
artikel |
15 |
How I treat chronic myelomonocytic leukemia
|
Solary, Eric |
|
|
130 |
2 |
p. 126-136 |
artikel |
16 |
Identifying and enriching platelet-producing human stem cell–derived megakaryocytes using factor V uptake
|
Sim, Xiuli |
|
|
130 |
2 |
p. 192-204 |
artikel |
17 |
JAK2 inhibitors for myeloproliferative neoplasms: what is next?
|
Bose, Prithviraj |
|
|
130 |
2 |
p. 115-125 |
artikel |
18 |
Myeloid leukemia associated with Down syndrome
|
Talsma, Caroline E. |
|
|
130 |
2 |
p. 230 |
artikel |
19 |
Myocardial fibrosis: the heart of diastole?
|
Detterich, Jon A. |
|
|
130 |
2 |
p. 104-105 |
artikel |
20 |
PD-1 blockade for relapsed lymphoma post–allogeneic hematopoietic cell transplant: high response rate but frequent GVHD
|
Haverkos, Bradley M. |
|
|
130 |
2 |
p. 221-228 |
artikel |
21 |
Response and progression on midostaurin in advanced systemic mastocytosis: KIT D816V and other molecular markers
|
Jawhar, Mohamad |
|
|
130 |
2 |
p. 137-145 |
artikel |
22 |
Soluble P-selectin is the smoke, not the fire
|
Gross, Peter L. |
|
|
130 |
2 |
p. 101-102 |
artikel |
23 |
Straus SE, Jaffe ES, Puck JM, et al. The development of lymphomas in families with autoimmune lymphoproliferative syndrome with germline Fas mutations and defective lymphocyte apoptosis. Blood. 2001;98(1):194-200.
|
|
|
|
130 |
2 |
p. 232 |
artikel |
24 |
Targeting deubiquitinases in CLL
|
Sampath, Deepa |
|
|
130 |
2 |
p. 100-101 |
artikel |
25 |
T cells lacking HDAC11 have increased effector functions and mediate enhanced alloreactivity in a murine model
|
Woods, David M. |
|
|
130 |
2 |
p. 146-155 |
artikel |
26 |
The challenge of hospital-related thrombosis
|
Bauer, Kenneth A. |
|
|
130 |
2 |
p. 97-98 |
artikel |
27 |
The effect of variation in donor platelet function on transfusion outcome: a semirandomized controlled trial
|
Kelly, Anne M. |
|
|
130 |
2 |
p. 214-220 |
artikel |
28 |
USP7 inhibition alters homologous recombination repair and targets CLL cells independently of ATM/p53 functional status
|
Agathanggelou, Angelo |
|
|
130 |
2 |
p. 156-166 |
artikel |